Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
University of Nebraska
University of Edinburgh
University of Washington
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals
University of Wisconsin, Madison
Montefiore Medical Center
Wake Forest University Health Sciences
Stanford University
Roswell Park Cancer Institute
NYU Langone Health